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Abstract
This is the final report of a three-year, Laboratory Directed Research and Development (LDRD) project at the Los Alamos Natioanl Laboratory (LANL). The kissing-loop RNA motif is thought to modulate different steps in the retroviral life cycle. Using an RNA folding protocol developed under this project, we are studying the folding of the potential kissing-loop motif in HIV. Using only limited information on base-pairings, and the constraints based on the connectivities, we are modeling the structure and the flexibility of this particular structural motif and have developed three predicted structures with low conformational energy. Following on our earlier work which analyzed correlated mutations in the V3 loop of HIV, we have developed an evolutionary model which incorporates non-independent mutations at different sequence postions in model sequences. This model takes into account the effects of the phylogenetic tree on the analysis of mutations, and shows a higher correspondence of correlated positions with structurally adjacent positions in the model than previous analyses. Additional research under this project has dealt with analyzing the dynamics of HIV in vivo. Using some simple models and patient data, we were able to establish for the first time some quantitative estimates of HIV dynamics in vivo. We found that 10 billion viral particles are produced and cleared each day in a typical mid-stage AIDS patient. Further, we found that the vast majority of the virus (99%) is produced by cells that only live about 1.5 days. These estimates suggest that if HIV replication can be completely stopped by potent drug combinations, then HIV and all cells infected by HIV may be able to be eliminated from the body after two to three years of completely effective treatment.
Background and Research Objectives
The rationale for this project is the crisis in health care that is a consequence of newly evolved pathogens, and the enhanced transmission of infectious diseases. The extraordinarily rapid spread of HIV (human immunodeficiency virus), resulting in enormous human suffering and devastation, is a disease in which the Laboratory has already made a major contribution via the HIV Sequence Database. The emergence of 'Principal Investigator, E-mail: asl@ tl3.lanl.gov persistent drug resistant strains of tuberculosis, malaria, and other infectious pathogens pose problems that may well prove to be as devastating as AIDS. The gravity of the situation has recently been described in numerous articles in the popular press as well as technical journals. To quote a Science lead editorial '* ... this is true biological warfare, in which new drugs designed by humans will become obsolete through mutations, only to be replaced by new human drugs and new mutations in a seesaw battle ... a long struggle with a premium on basic research to improve our stratagems and applied research to develop new magic bullets is clearly the prognosis for the future." wealth of experimental data currently being generated into a comprehensible framework which would allow reasoned selection of vaccine candidates and therapeutic agents, rapid evaluation of changes in pathogens displaying drug resistance, and new means to overcome this resisistance.
The objective is to develop a comprehensive, integrated program to bring the great
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Importance to LANL's Science and Technology Base and National
R&D Needs
The ability to repond effectively to such major health threats will depend largely upon the ability to design effective and inexpensive vaccines and therapeutic agents. Vast amounts of complex biomedical information relevant to the problem of vaccine and therapeutic design are being generated by modem experimental techniques and deposited in national and international databases. The HIV Sequence Database at Los Alamos, which is the international repository for molecular data pertaining to the AIDS viruses, is one such important data resource, and the Los Alamos team led by Gerry Myers (co-PI) has played a key role in HIV sequence analysis. A flood of information is fast approaching about other pathogens and their continuing evolution; however, approaches to solving the complex problems of treatment of infectious diseases are seriously lagging behind the successful acquisition, processing and publishing of molecular data.
There exists a critical need for computational and theoretical efforts aimed at assimilating, integrating and interpreting vast collections of "atomized" biomedical information. This is the program we are developing at Los Alamos. The central task of the computation and theory effort is to synthesize the data into a coherent structure, and to construct, critique and interpret biochemical and immunological correlations in order to develop techniques for designing new drugs and therapies. The magnitude of the problems confronting health care nationally and internationally demands a highly interdisciplinary scientific approach, as well as cooperative interactions between private industry and government.
. Scientific Approach and Accomplishments
Following on our earlier work which analyzed correlated mutations in the V3 loop of HIV, we have developed an evolutionary model which incorporates non-independent mutations at different sequence positions in model sequences. This model takes into account the effects of the phylogenetic tree on the analysis of mutations, and shows a higher correspondence of correlated positions with structurally adjacent positions in the model than previous analyses.
in vivo. Using some simple models and patient data, we were able to establish for the first time some quantitative estimates of HIV dynamics in vivo. We found that 10 billion viral particles are produced and cleared each day in a typical mid-stage AIDS patient. Further, we found that the vast majority of the virus (99%) is produced by cells that only live about 1.5 days. These estimates suggest that if HIV replication can be completely stopped by potent drug combinations, then HIV and all cells infected by HIV may be able to be eliminated from the body after two to three years of completely effective treatment.
The kissing-loop RNA motif consists of two hairpins with complementary loop sequences. In retroviruses, one such motif is thought to facilitate the genome dimerization (Haddrick et al., 1996; Laughrea and Jette, 1996) and /or packaging (l3erkhout and van Wamel, 1996) . It is also a unique protein recognition site in regulation of ColEl plasmid DNA replication (Simon and Kleckner, 1988) . In HIV, there exists a potential kissing-loop motif between a hairpin sequence in the TAR region and a homologous hairpin sequence (TAR*) in the GAG gene (about 800 bps downstream from the TAR sequence). We have found that the TAR-TAR* sequence motif is conserved in HIV-1, HIV-2, chimpanzee, as well as African green monkey viruses. Since the kissing-loop motif is thought to modulate different steps in the retroviral life cycle (e.g., recombination, translation, and encapsidation), it is very important to study its structure for the purpose of understanding its role in regulation as well as therapeutic functions.
Using an RNA folding protocol developed in our laboratory, we are studying the folding of this particular kissing-loop motif. The sequence and the secondary structure of the motif are shown in Fig. 1 . Based on NMR imino proton spectra, Tinoco's lab has determined that five of the six bases in the loop region of the hairpin are involved in baseAdditional research under this project has dealt with analyzing the dynamics of HIV pairings (Chang and Tinoco Jr., 1994) . Using only the limited information of basepairings and the constraints based on the connectivities, we are modeling the structure and the flexibility of this particular structural motif. Initial structural models were constructed by short runs of Monte Carlo simulations using only the non-bonded energy. As a result, 61 unique structures were generated. Each of these 61 initial modeled structures was then subjected to a refinement of 5,000 cycles of minimization using AMBER. The three predicted structures that have low conformational energies are shown in Fig. 2 .
This past year we prepared two NIH grant proposals to fund research on human immunodeficiency virus (HIV) dynamics in vivo. The proposals were for collaborative research with David Ho, head of the Aaron Diamond AIDS Research Center (ADARC), Rockefeller University, New York. The first grant request was not funded but on resubmission it was ranked at the highest possible priority, first percentile of all proposals, and should be funded shortly as a subcontract from ADARC. A second NIH grant proposal ,"Immune System Modeling" (A. Perelson, PI), has been funded beginning March 1996 for five years. Also in this past year we have prepared a grant proposal to DOE titled "Neural Net Approaches to Empirical Protein Potentials," which has been funded starting in F Y 1997 for three years.
In other work we are laying the groundwork for a major new initiative to create a molecular database for diverse infectious pathogens. We have continuing discussion with the Centers for Disease Control concerning the establishment of an influenza database. 
